Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cantonetti

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2016
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemiaG Del Poeta, M Postorino, L Pupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patientsP L Zinzani, M Magagnoli, P Galieni, et al.
Annals of Hematology|October 8, 2015
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapyM Postorino, L Pupo, I Provenzano, et al.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Bone Marrow Transplantation|August 16, 2016
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized studyF Marchesi, A Tendas, D Giannarelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donorC Cerva, L Colagrossi, G Maffongelli, et al.
Bone Marrow Transplantation|February 15, 2018
BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplantF Marchesi, S Capria, D Giannarelli, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Journal of Bone Oncology|December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?O Annibali, M T Petrucci, D Santini, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2016
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemiaG Del Poeta, M Postorino, L Pupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patientsP L Zinzani, M Magagnoli, P Galieni, et al.
Annals of Hematology|October 8, 2015
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapyM Postorino, L Pupo, I Provenzano, et al.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Bone Marrow Transplantation|August 16, 2016
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized studyF Marchesi, A Tendas, D Giannarelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donorC Cerva, L Colagrossi, G Maffongelli, et al.
Bone Marrow Transplantation|February 15, 2018
BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplantF Marchesi, S Capria, D Giannarelli, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Journal of Bone Oncology|December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?O Annibali, M T Petrucci, D Santini, et al.
Pageof 4